Similar articles for PMID: 29102926

Year	Number of Results
1948	1
2004	2
2005	8
2006	4
2007	8
2008	7
2009	2
2010	3
2011	11
2012	7
2013	7
2014	7
2015	9
2016	14
2017	11
2018	8
2019	3
2020	4
2021	1
2022	2

1

The Contribution of MMP-8 Promoter Genotypes to Childhood Leukemia.

Pei JS, Chang WS, Hsu PC, Hung YW, Cheng SP, Tsai CW, Bau DT, Gong CL. Pei JS, et al. In Vivo. 2017 Nov-Dec;31(6):1059-1064. doi: 10.21873/invivo.11170. In Vivo. 2017. PMID: 29102926 Free PMC article.

2

The Association of MMP-8 Genotypes with Pterygium.

Hu PS, Chang WS, Chou AK, Hsia NY, Hung YW, Lin CW, Wu CW, Huang CY, Wu MF, Liao CH, Tsai CW, Bau DT, Gong CL. Hu PS, et al. In Vivo. 2018 Jan-Feb;32(1):41-46. doi: 10.21873/invivo.11202. In Vivo. 2018. PMID: 29275297 Free PMC article.

3

The Contribution of MMP-8 Promoter Polymorphisms in Lung Cancer.

Shen TC, Hsia TC, Chao CY, Chen WC, Chen CY, Chen WC, Lin YT, Hsiao CL, Chang WS, Tsai CW, Bau DT. Shen TC, et al. Anticancer Res. 2017 Jul;37(7):3563-3567. doi: 10.21873/anticanres.11726. Anticancer Res. 2017. PMID: 28668847

4

The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer.

Hsiao CL, Liu LC, Shih TC, Chuang CL, Chen GL, Wang HC, Pan SY, Shen TC, Tsai CW, Chang WS, Way TD, Chung JG, Bau DT. Hsiao CL, et al. Anticancer Res. 2018 Apr;38(4):2181-2185. doi: 10.21873/anticanres.12459. Anticancer Res. 2018. PMID: 29599337

5

The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility.

Hung YW, Tsai CW, Wu CN, Shih LC, Chen YY, Liu YF, Hung HS, Shen MY, Chang WS, Bau DT. Hung YW, et al. In Vivo. 2017 Jul-Aug;31(4):585-590. doi: 10.21873/invivo.11098. In Vivo. 2017. PMID: 28652424 Free PMC article.

6

Association of Matrix Metallopeptidase-2 Promoter Polymorphisms With the Risk of Childhood Leukemia.

Hsu PC, Pei JS, Chen CC, Chang WS, Kuo CC, Cheng SP, Tsai CW, Bau DT, Gong CL. Hsu PC, et al. Anticancer Res. 2019 Mar;39(3):1185-1190. doi: 10.21873/anticanres.13228. Anticancer Res. 2019. PMID: 30842148

7

Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk.

Kuo CC, Tsai CW, Chang WS, Shen TC, Tzeng HE, Li CH, Wang YC, Tsai FJ, Bau DT. Kuo CC, et al. Anticancer Res. 2020 Oct;40(10):5751-5756. doi: 10.21873/anticanres.14591. Anticancer Res. 2020. PMID: 32988902

8

Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer.

Tsai TH, Wang YM, Chang WS, Tsai CW, Wu HC, Hsu HM, Wang YC, Li HT, Gong CL, Bau DT, Li CY. Tsai TH, et al. Anticancer Res. 2018 Sep;38(9):5159-5164. doi: 10.21873/anticanres.12838. Anticancer Res. 2018. PMID: 30194163

9

Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia.

Pei JS, Chou AK, Hsu PC, Tsai CW, Chang WS, Wu MF, Wu MH, Hsia TC, Cheng SP, Bau DT. Pei JS, et al. Anticancer Res. 2017 Dec;37(12):6679-6684. doi: 10.21873/anticanres.12126. Anticancer Res. 2017. PMID: 29187444

10

Significant Association of Interleukin-10 Polymorphisms with Childhood Leukemia Susceptibility in Taiwan.

Lo WJ, Chang WS, Hsu HF, Ji HX, Hsiao CL, Tsai CW, Yeh SP, Chen CM, Bau DT. Lo WJ, et al. In Vivo. 2016 May-Jun;30(3):265-9. In Vivo. 2016. PMID: 27107085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed